Drug Research
Accelerating Drug Development Through CDMO Partnerships
Based on current market analyses, global pharmaceutical spending is projected to reach approximately $1,742 billion by 2025. Concurrently, spending on COVID-19 vaccines and therapeutics is...
Drug Research
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
Samsung Biologics announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance.
Bristol Myers Squibb...
Drug Research
As Lonza CEO departs, Catalent scoops up rival CDMO’s bioscience business head to lead biologics
Mere hours after it surfaced that Lonza’s CEO, Pierre-Alain Ruffieux, will step down, the Swiss CDMO has lost another major executive. And this time, the...
Drug Research
Drug Diversion Detection Through AI Effective In Hospitals
Research conducted by Wolters Kluwer, an information and software company, suggests that artificial intelligence (AI) can potentially reduce drug diversion in hospitals. The study revealed...
Drug Research
Sygnature Discovery’s hit finding expertise in high demand as cardiac biotech, River BioMedics, receives an additional €2M seed investment
Sygnature Discovery (Sygnature) is delighted to announce that its customer, River BioMedics, has raised an additional €2M in seed funding to continue its life-saving cardiovascular...
Drug Research
CordenPharma Inaugurates Increased Peptide Production of the Largest Worldwide SPPS Manufacturing Plant to Meet Growing Market Demand
Following the signature of a multi-year large scale peptide manufacturing agreement earlier this year, CordenPharma is pleased to announce the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.
After kicking off...
Drug Research
Torx Software announces global drug discovery collaboration with CDD Vault
Torx Software Limited, announces a collaboration with CDD Vault to facilitate the seamless synthesis and registration of new compounds during the small-molecule drug discovery process.
Torx...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.